Global Subcutaneous Immunoglobulin (SCIg) Market is Expected to Grow a CAGR of 20.7% During the Forecast Period

The latest market report published by Credence Research “Global Subcutaneous Immunoglobulin (SCIg) Market: Growth, Future Prospects, and Competitive Analysis, 2015 – 2027”. The global Subcutaneous Immunoglobulin (SCIg) market generated revenue of around USD 2,136.71 million in 2020 and anticipated to grow at a CAGR of over 20.7% during the forecast period from 2021 to 2027 to reach around USD 8,435.62 million in 2027.

Global Subcutaneous Immunoglobulin (SCIg) Market, 2020 – 2027 (USD Million)

Global Subcutaneous Immunoglobulin (SCIg) Market

Subcutaneous Immunoglobulin (SCIg) is basically a processed plasma collected from doners and free from contamination in order to maintain products safety and integrity. Subcutaneous Immunoglobulin (SCIg) can be administered through intravenous as well as subcutaneous methods. The Subcutaneous Immunoglobulin (SCIg) is administered subcutaneously.

Key Trends in Global Subcutaneous Immunoglobulin (SCIg) Market

Growing demand for Polyvalent IG across the world

Ever rising number of patients requiring Immunoglobulin will drive demand for IG in the years to come. There are more than 300 diseases included in group of Primary Immunodeficiencies. Incidence rate of Primary Immunodeficiencies is around 1:10,000 and they are more predominant in children. Immunoglobulin has been used as antibody replacement treatment in primary immunodeficiency diseases (PIDDs) for numerous years. Its role as a therapeutic agent has extended over the past few decades as its anti-inflammatory and immune-modulatory mechanisms of action have been elucidated.

The Global Polyvalent IG Market (IVIG and SCIG) from 1986 to 2020, with Projected Global Demand Through 2024

Global Subcutaneous Immunoglobulin (SCIg) Market

Impact of COVID 19 on Subcutaneous Immunoglobulin (SCIg) Market

Impact of COVID 19 was quite evident on growth rate of The Subcutaneous Immunoglobulin (SCIg) market in 2020 and likely to affect the revenue generation in 2021 as well on the account of second wave of COVID 19 in India, Europe, Brazil and U.S. However, successful vaccination program undertaken by most of the nations is also expected to improve the overall economies to restore the global supply as well as demand and thus lower the impact of COVID 19.

Global Subcutaneous Immunoglobulin (SCIg) Market by Application Insights

Primary Immunodeficiency Diseases, Secondary Immunodeficiency Diseases, Primary Immunodeficiency Diseases, Neurological Disorders and Bleeding Disorder are some of the major types of applications for Subcutaneous Immunoglobulin (SCIg). Subcutaneous Immunoglobulin (SCIg) market was dominated by the global Primary Immunodeficiency Diseases application market with over 60% share in total revenue generation.

Primary Immunodeficiency Diseases Segment to Dominate the global Subcutaneous Immunoglobulin (SCIg) market

Global Subcutaneous Immunoglobulin (SCIg) Market by Application, 2020

Global Subcutaneous Immunoglobulin (SCIg) Market

Global Subcutaneous Immunoglobulin (SCIg) Market by End-user Insights

Hospital, Homecare and Clinics are major end-users of Subcutaneous Immunoglobulin (SCIg). Homecare segment dominated with over 60% share in total revenue generated by the global Subcutaneous Immunoglobulin (SCIg) industry in 2020. It is also expected to advance at rapid CAGR during the forecast period.

Global Subcutaneous Immunoglobulin (SCIg) Market Share by End-user, 2020

Global Subcutaneous Immunoglobulin (SCIg) Market

Global Subcutaneous Immunoglobulin (SCIg) Market by Regional Insights

North America was the largest market for Subcutaneous Immunoglobulin (SCIg) in 2020 and accounted for over 40% share in total revenue generation. Europe was the second leading market for Subcutaneous Immunoglobulin (SCIg) industry in 2020. However, Asia Pacific is poised to grow at lucrative CAGR over the forecast period.

Global Subcutaneous Immunoglobulin (SCIg) Market Competitive Landscape

Most prominent players in the global Subcutaneous Immunoglobulin (SCIg) market include Biotest AG, CSL Limited, Grifols SA, Kedrion S.p.A, Octapharma AG, Takeda Pharmaceutical Company Limited (Shire), Bio Products Laboratory Ltd., LFB S.A. and others. The report covers very detailed profiles of these key players.

Global Subcutaneous Immunoglobulin (SCIg) Market, Company Distribution Network, 2020

Global Subcutaneous Immunoglobulin (SCIg) Market

Market Segmentation

Global Subcutaneous Immunoglobulin (SCIg) Market by Application, 2015 – 2027

· Primary Immunodeficiency Diseases

· Secondary Immunodeficiency Diseases

· Neurological Disorders

· Bleeding Disorders

· Others

Global Subcutaneous Immunoglobulin (SCIg) Market by End-user, 2015 – 2027

· Hospital

· Homecare

· Clinics

Global Subcutaneous Immunoglobulin (SCIg) Market by Region, 2015 – 2027

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East and Africa

Global Subcutaneous Immunoglobulin (SCIg) Market: Key Players

· Biotest AG

· CSL Limited

· Grifols SA

· Kedrion S.p.A

· Octapharma AG

· Takeda Pharmaceutical Company Limited (Shire)

· Bio Products Laboratory Ltd.

· LFB S.A.

. Others